Better outcomes through better treatment.
Understanding and applying improved treatments is the goal of our clinical research.
At Dayton Physicians Network, our doctors actively participate in cutting edge clinical research to further this goal. We believe that participating in research helps to eliminate the threat in the future. We know that by participating in a clinical trial, you or your loved one have a unique opportunity to help in meeting this goal while receiving leading edge treatment.
We believe the incremental progress that we can provide through well-done clinical research which helps our patients both in the present and in the future. Participation in well-designed FDA approved clinical trials while providing vital information and possible benefits contributes to the benefit of other patients.
What Is A Clinical Trial
In a clinical trial, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or changes to participants’ behavior, such as diet. Clinical trials may compare a new medical approach to a standard one that is already available, to a placebo that contains no active ingredients, or no intervention. Some clinical trials compare interventions that are already available to each other. When a new product or approach is being studied, it is not usually known whether it will be helpful, harmful, or no different than available alternatives (including no intervention). The investigators try to determine the safety and efficacy of the intervention by measuring certain outcomes in the participants.
These studies are done under strict guidelines to make sure that the safety of the patient is the number one priority. Before a medication or therapy can become a clinical trial, it must pass through numerous stages of intensive development and testing and the U.S. Food and Drug Administration must approve them.
Should You Consider A Clinical Trial
A clinical trial could be an option for you; however, we know that there is always an uncertainty when thinking about a clinical trial. Talk to your doctor about which trial may be the best for you based on your diagnosis. There is no right or wrong choice when it comes to deciding to participate. This is a very personal decision that depends on many factors including the risks and benefits of the trial. You also have to determine what you hope to achieve by participating.
Knowing as much as possible about clinical trials in general, and specifically about ones you might participate in, can help you to make the best decision for you…read more at National Cancer Institute.
One thing is certain. If you decide to participate in a clinical trial, you can rest assured that you will continue to receive compassionate, quality care throughout your treatment at Dayton Physicians Network. It is important to note that you can withdraw from any clinical trial at any time should you choose to do so.
Find A Clinical Trial
We are dedicated to offering you the latest and most innovative cancer care. Our doctors and research team will match you to the trial that is right for you. They will also discuss the risks and benefits of participating in a particular trial. We collaborate with Dayton Clinical Oncology Program as well as offering the following trials to bring research right here… close to home.
We are currently enrolling for the following trials:
Advanced Liver Cancer (Previously Treated) Phase III
Advanced Liver Cancer (Newly Diagnosed) Phase III
Comparing Immunotherapy (BGB A317/tislelizumab) with current standard treatment (sorafenib) NCT 03412773
Advanced Triple Negative Breast Cancer Phase II
Comparing standard treatment (olaparib) alone or in combination with DNA-targeted agents NCT 03330847
Advanced Prostate Cancer (Previously treated) Phase III
Radiopharmaceutical therapy PSMA-617-01 NCT 03511664
Advanced Urothelial Cancer (Previously treated) Phase III
Comparing a Monoclonal Antibody with Chemotherapy NCT 03474107
Advanced Renal Cell Cancer Phase III
Blinded: TKI (Pazopanib) with Abexinostat or placebo NCT 03592472
Advanced Breast Cancer HER2 Positive (Previously treated) Phase III
Two studies comparing DS-8201a (anit-HER2-antibody) with either T-DM1 (ado-trastuzumab emtansine or Investigator choice standard of care NCT 03523585 NCT 03529110
Advanced Gastric/Gastro-esophageal Junction Cancer Phase III
Comparing Zolbetuximab (IMAB362) plus standard treatment with Placebo plus standard treatment. NCT 03504397
Prostate Cancer with Cardiovascular (CV) Disease Phase III
Comparing occurrences of CV events in patients receiving Degarelix or Luprolide. NCT 02663908
Breast Cancer – Current or Historical
Survey regarding Access to Care
Biomarker study for patients receiving checkpoint inhibitors (CPI) for the first time. Blood draws only.
We’re here for you with clinical trials close to home because without research, there would be no progress in health care.